Ziva DRA supports pharmaceutical companies with pharmacovigilance planning, safety-process coordination, adverse-event workflow support, regulatory documentation and ongoing post-market compliance activities.
Pharmacovigilance helps organizations identify, evaluate, document and manage safety information associated with pharmaceutical products throughout their lifecycle.
Ziva DRA supports pharmaceutical companies in structuring pharmacovigilance processes, organizing safety-related documentation and coordinating regulatory activities associated with post-market product safety.
Pharmacovigilance can also be integrated with medicine registration, dossier preparation and broader pharmaceutical regulatory support where a company requires a more complete lifecycle model.
The final scope depends on the product, company responsibilities and applicable safety requirements. Engagements may include the following workstreams.
Review existing pharmacovigilance arrangements and identify process or documentation gaps.
Support development of structured safety intake, assessment and escalation workflows.
Support documentation and coordination of relevant adverse-event information.
Support preparation and maintenance of safety-related regulatory records.
Support applicable safety reporting and regulatory follow-up activities.
Support ongoing safety monitoring and continuing post-market compliance activities.
A consistent safety workflow helps ensure that relevant information is captured, assessed, documented and managed appropriately.
Capture relevant product safety information.
Review the information against applicable requirements.
Maintain required case and safety records.
Support applicable regulatory reporting activities.
Support continuing post-market safety oversight.
Pharmacovigilance should be structured around defined responsibilities, documented workflows and current product-specific requirements.
A clear operating model helps establish how safety information moves through the organization.
Documentation requirements should be confirmed against the product and current applicable rules.
Companies requiring ongoing product safety and post-market support.
Overseas companies requiring Bangladesh-focused pharmacovigilance support.
Regulatory teams coordinating product registration and post-approval compliance.
Safety teams requiring structured local regulatory support and coordination.
Yes. Ziva DRA can support international pharmaceutical companies requiring Bangladesh-focused safety and compliance coordination.
No. Pharmacovigilance generally forms part of continuing post-market product safety and lifecycle compliance.
Yes. A gap assessment can help identify process, documentation and compliance areas that may require attention.
Yes. Medicine registration, dossier work and pharmacovigilance can be coordinated as related regulatory workstreams where appropriate.
Share your product portfolio, current safety setup and regulatory requirements with Ziva DRA so the appropriate pharmacovigilance scope can be assessed.